Apelin-13 administration protects against ischaemia/reperfusion-mediated apoptosis through the FoxO1 pathway in high-fat diet-induced obesity

British Journal of Pharmacology

Volumn 173, Issue 11, 2016, Pages 1850-1863

  Boal, Frederic ^a,b   Timotin, Andrei ^a,b   Roumegoux, Jessica ^a,b   Alfarano, Chiara ^a,b   Calise, Denis ^b,c   Anesia, Rodica ^a,b   Parini, Angelo ^a,b   Valet, Philippe ^a,b   Tronchere, Helene ^a,b   Kunduzova, Oksana ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b University Hospital of Toulouse   (France)

^c Microsurgery Services   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APELIN; APELIN 13; CASPASE 3; MESSENGER RNA; MITOCHONDRIAL DNA; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG; APELIN-13 PEPTIDE; FOXO1 PROTEIN, MOUSE; SIGNAL PEPTIDE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARDIAC MUSCLE CELL; CELL HYPOXIA; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIET INDUCED OBESITY; GENE EXPRESSION; HEART INFARCTION SIZE; HEART MITOCHONDRION; HEART PROTECTION; LIPID DIET; MALE; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; ANIMAL; C57BL MOUSE; DRUG EFFECTS; METABOLISM; MYOCARDIAL REPERFUSION INJURY; OBESITY; PATHOLOGY;

ANIMALS; APOPTOSIS; DIET, HIGH-FAT; FORKHEAD BOX PROTEIN O1; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED C57BL; MYOCARDIAL REPERFUSION INJURY; OBESITY;

EID: 84964409753     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13485     Document Type: Article

References (49)

1. Alexander SPH, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E, et al., (2015a). The Concise Guide to PHARMACOLOGY 2015/16: Overview. Br J Pharmacol 172: 5729-5143.
2. Alexander SPH, Davenport AP, Kelly E, Marrion N, Peters JA, Benson HE, et al., (2015b). The Concise Guide to PHARMACOLOGY 2015/16: G protein-coupled receptors. Br J Pharmacol 172: 5744-5869.
3. Alexander SPH, Fabbro D, Kelly E, Marrion N, Peters JA, Benson HE, et al., (2015c). The Concise Guide to PHARMACOLOGY 2015/16: Enzymes. Br J Pharmacol 172: 6024-6109.
4. Alfarano C, Foussal C, Lairez O, Calise D, Attané C, Anesia R, et al., (2014). Transition from metabolic adaptation to maladaptation of the heart in obesity: role of apelin. Int J Obes (Lond) 39: 312-320.
5. Attane C, Foussal C, Le Gonidec S, Benani A, Daviaud D, Wanecq E, et al., (2012). Apelin treatment increases complete Fatty Acid oxidation, mitochondrial oxidative capacity, and biogenesis in muscle of insulin-resistant mice. Diabetes 61: 310-320.
6. Awad H, Nolette N, Hinton M, Dakshinamurti S, (2014). AMPK and FoxO1 regulate catalase expression in hypoxic pulmonary arterial smooth muscle. Pediatr Pulmonol 49: 885-897.
7. Battiprolu P, Hojayev B, Jiang N, Wang ZV, Luo X, Iglewski M, et al., (2012). Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice. J Clin Invest 122: 1109-1118.
8. Bianchi P, Kunduzova O, Masini E, Cambon C, Bani D, Raimondi L, et al., (2005). Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury. Circulation 112: 3297-3305.
9. Bluher M, (2013). Adipose tissue dysfunction contributes to obesity related metabolic diseases. Best Pract Res Clin Endocrinol Metab 27: 163-177.
10. Boal F, Guetzoyan L, Sessions RB, Zeghouf M, Spooner RA, Lord JM, et al., (2010). LG186: An inhibitor of GBF1 function that causes Golgi disassembly in human and canine cells. Traffic 11: 1537-1551.
11. Braunersreuther V, Mach F, Montecucco F, (2012). Reactive oxygen-induced cardiac intracellular pathways during ischemia and reperfusion. Curr Signal Transduct Ther 7: 89-95.
12. Curtis MJ, Bond RA, Spina D, Ahluwalia A, Alexander SPA, Giembycz MA, et al., (2015). Experimental design and analysis and their reporting: new guidance for publication in BJP. Br J Pharmacol 172: 3461-3471.
13. Dray C, Debard C, Jager J, Disse E, Daviaud D, Martin P, et al., (2010). Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans. Am J Physiol Endocrinol Metab 298: E1161-E1169.
14. Dray C, Knauf C, Daviaud D, Waget A, Boucher J, Buléon M, et al., (2008). Apelin stimulates glucose utilization in normal and obese insulin-resistant mice. Cell Metab 8: 437-445.
15. Evans-Anderson H, Alfieri C, Yutzey E, (2008). Regulation of cardiomyocyte proliferation and myocardial growth during development by FOXO transcription factors. Circ Res 102: 686-694.
16. Ferber E, Peck B, Delpuech O, Bell GP, East P, Schulze A, et al., (2011). FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression. Cell Death Differ 19: 968-979.
17. Foussal C, Lairez O, Calise D, Pathak A, Guilbeau-Frugier C, Valet P, et al., (2010). Activation of catalase by apelin prevents oxidative stress-linked cardiac hypertrophy. FEBS Lett 584: 2363-2370.
18. Furuyama T, Kitayama K, Shimoda Y, Ogawa M, Sone K, Yoshida-Araki K, et al., (2004). Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice. J Biol Chem 279: 34741-34749.
19. Kadoglou N, Lampropoulos S, Kapelouzou A, Gkontopoulos A, Theofilogiannakos EK, Fotiadis G, et al., (2010). Serum levels of apelin and ghrelin in patients with acute coronary syndromes and established coronary artery disease-KOZANI STUDY. Transl Res 155: 238-246.
20. Kang P, Izumo S, (2000). Apoptosis and heart failure a critical review of the literature. Circ Res 86: 1107-1113.
21. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). Animal research: Reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
22. Kleinz MJ, Davenport AP, (2005). Emerging roles of apelin in biology and medicine. Pharmacol Ther 107: 198-211.
23. Kleinz MJ, Skepper JN, Davenport AP, (2005). Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells. Regul Pept 126: 233-240.
24. Konstantinidis K, Whelan R, Kitsis R, (2012). Mechanisms of cell death in heart disease. Arterioscler Thromb Vasc Biol 32: 1552-1562.
25. Kops G, Dansen T, Polderman P, Saarloos I, Wirtz K, Coffer P, et al., (2002). Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419: 316-321.
26. Kowluru A, Matti A, (2012). Hyperactivation of protein phosphatase 2 A in models of glucolipotoxicity and diabetes: potential mechanisms and functional consequences. Biochem Pharmacol 84: 591-597.
27. Kuba K, Zhang L, Imai Y, Arab S, Chen M, Maekawa Y, et al., (2007). Impaired heart contractility in Apelin gene-deficient mice associated with aging and pressure overload. Circ Res 101: e32-e42.
28. Mani K, (2008). Programmed cell death in cardiac myocytes: strategies to maximize post-ischemic salvage. Heart Fail Rev 13: 193-209.
29. Maury E, Ehala-Aleksejev K, Guiot Y, Detry R, Vandenhooft A, Brichard S, (2007). Adipokines oversecreted by omental adipose tissue in human obesity. Am J Physiol Endocrinol Metab 293: E656-E665.
30. McGrath JC, Lilley E, (2015). Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP. Br J Pharmacol 172: 3189-3193.
31. Medema R, Kops G, Bos J, Burgering B, (2000). AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404: 782-787.
32. Nakamura K, Fuster J, Walsh K, (2014). Adipokines: a link between obesity and cardiovascular disease. J Cardiol 63: 250-259.
33. Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al., (2014). The IUPHAR/BPS guide to PHARMACOLOGY: an expert-driven knowledge base of drug targets and their ligands. Nucleic Acids Res 42: D1098-D1106.
34. Pchejetski D, Foussal C, Alfarano C, Lairez O, Calise D, Guilbeau-Frugier C, et al., (2012). Apelin prevents cardiac fibroblast activation and collagen production through inhibition of sphingosine kinase 1. Eur Heart J 33: 2360-2369.
35. Pchejetski D, Kunduzova O, Dayon A, Calise D, Seguelas MH, Leducq N, et al., (2007). Oxidative stress-dependent sphingosine kinase-1 inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis. Circ Res 100: 41-49.
36. Ponugoti B, Dong G, Graves D, (2012). Role of forkhead transcription factors in diabetes-induced oxidative stress. Exp Diabetes Res 2012: 939751.
37. Rana J, Mukamal K, Morgan J, Muller J, Mittleman M, (2004). Obesity and the risk of death after acute myocardial infarction. Am Heart J 147: 841-846.
38. Raju I, Kannan K, Abraham E, (2013). FoxO3a Serves as a Biomarker of Oxidative Stress in Human Lens Epithelial Cells under Conditions of Hyperglycemia. PLoS One 8: e67126.
39. Sengupta A, Molkentin J, Paik J, DePinho R, Yutzey K, (2011). FoxO transcription factors promote cardiomyocyte survival upon induction of oxidative stress. J Biol Chem 286: 7468-7478.
40. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou M, et al., (1998). Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 251: 471-476.
41. Tycinska A, Sobkowicz B, Mroczko B, Sawicki R, Musial W, Dobrzycki S, et al., (2010). The value of apelin-36 and brain natriuretic peptide measurements in patients with first ST-elevation myocardial infarction. Clin Chim Acta 411: 2014-2018.
42. Ullman K, Powers M, Forbes D, (1997). Nuclear export receptors: from importin to exportin. Cell 90: 967-970.
43. Wang W, McKinnie S, Patel V, Haddad G, Wang Z, Zhabyeyev P, et al., (2013). Loss of apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: therapeutic potential of synthetic apelin analogues. J Am Heart Assoc 2: e000249.
44. Wang X, (2001). The expanding role of mitochondria in apoptosis. Genes Dev 15: 2922-2933.
45. Wang Y, Zhou Y, Graves D, (2014). FOXO transcription factors: their clinical significance and regulation. Biomed Res Int 2014; Article ID 925350, 13 pages.
46. Weir R, Chong K, Dalzell J, Petrie C, Murphy C, Steedman T, et al., (2009). Plasma apelin concentration is depressed following acute myocardial infarction in man. Eur J Heart Fail 11: 551-558.
47. Wencker D, Chandra M, Nguyen K, Miao W, Garantziotis S, Factor SM, et al., (2003). A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest 111: 1497-1504.
48. Zhao Y, Wang Y, Zhu WG, (2011). Applications of post-translational modifications of FoxO family proteins in biological functions. J Mol Cell Biol 3: 276-282.
49. Zhen EY, Higgs RE, Gutierrez AJ, (2013). Pyroglutamyl apelin-13 identified as the major apelin isoform in human plasam. Anal Biochem 442: 1-9.